TFS
ETTX

TrustCore Financial Services’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

TrustCore Financial Services’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed – – 1213
2022
Q2 		$0 Hold
100
– – ﹤0.01% 1151
2022
Q1 		$0 Hold
100
– – ﹤0.01% 1128
2021
Q4 		$0 Hold
100
– – ﹤0.01% 1089
2021
Q3 		$0 Hold
100
– – ﹤0.01% 1180
2021
Q2 		$0 Hold
100
– – ﹤0.01% 1127
2021
Q1 		$0 Hold
100
– – ﹤0.01% 1019
2020
Q4 		$0 Hold
100
– – ﹤0.01% 973
2020
Q3 		$0 Hold
100
– – ﹤0.01% 953
2020
Q2 		$0 Hold
100
– – ﹤0.01% 974
2020
Q1 		$0 Hold
100
– – ﹤0.01% 986
2019
Q4 		$0 Hold
100
– – ﹤0.01% 992
2019
Q3 		$1K Hold
100
– – ﹤0.01% 934
2019
Q2 		$1K Hold
100
– – ﹤0.01% 894
2019
Q1 		$1K Buy
+100
New +$599 ﹤0.01% 824

TrustCore Financial Services's ETTX Position: Q3 2022 in Review

TrustCore Financial Services sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 100 shares.

TrustCore Financial Services first reported a position in ETTX in Q1 2019 and held it in 14 quarters. The position peaked at $1K in Q3 2019. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • TrustCore Financial Services reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 100 Entasis Therapeutics Holdings Inc. shares in Q3 2022.
  • TrustCore Financial Services first reported a position in Entasis Therapeutics Holdings Inc. in Q1 2019 and held it in 14 quarters.
  • TrustCore Financial Services's Entasis Therapeutics Holdings Inc. position peaked at $1K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on TrustCore Financial Services's 13F filing for Q3 2022, filed 3 Nov 2022.